The IP Lounge: In-house Ones to Watch, law firms’ AI opportunities

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

The IP Lounge: In-house Ones to Watch, law firms’ AI opportunities

MIP Podcast newsletter header banner sample-2000.jpg

In the latest episode, we discuss our latest list of in-house rising stars and analyse developments from AI work for law firms to legal market news in Canada


In this episode, the team unpicks some of the biggest talking points from the last few weeks.

Editor Max Walters is joined by Rani Mehta, senior reporter for the Americas, and Sukanya Sarkar, our special projects editor in Asia.

Top of the list is the latest IP Ones to Watch. Now in its fourth year, the list showcases peer-nominated up-and-coming talent in the in-house profession.

Meanwhile, Australia-based listed company IPH has been in the news regarding its activities in Canada. We discuss all the latest updates.

We also look at artificial intelligence, the latest on a proposed ban on non-compete agreements and the impact on trade secrets, and what the Managing IP team is looking ahead to in the coming weeks.

We will be back with a new episode in October. Thank you for listening.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article